Lyme Disease

Scientists Prove Safety, Effectiveness of Lyme Vaccine in Children

Published in Vaccine Weekly, May 24th, 2000

Researchers have demonstrated that a vaccine against Lyme disease not only is safe for children ages four to 18, but also raised children's protective antibodies against the Lyme disease organism to higher levels than in adults.

The findings were presented at a joint meeting of the Pediatric Academic Societies (made up of the American Pediatric Society, the Society for Pediatric Research, and the Ambulatory Pediatric Association) and the American Academy of Pediatrics on May 14, 2000.

The vaccine, LYMErix^TM Lyme disease vaccine (recombinant OspA), had previously been tested in adults but not in children.

Lead author...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2000-05-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry